ВЫБОР АНТИКОАГУЛЯНТА У БОЛЬНЫХ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ, ПОДВЕРГАЕМЫХ КАРДИОВЕРСИИ
Аннотация
Рассматриваются критерии выбора антикоагулянта у больных с фибрилляцией предсердий, подвергаемых кардиоверсии, приводятся данные рандомизированных клинических исследований, анализируются рекомендации.
Список литературы
1. Zoll PM, Paul MH, Linenthal AJ et al. The effects of external electric currents on the heart: control of cardiac rhythm and induction and termination of cardiac arrhythmias // Circulation. 1956; 14: 745-756.
2. Вишневский А.А, Цукерман Б.М., Смеловский С.И. // Клиническая медицина, 1959, № 8, С.26.
3. Lown B., Amarasingham R., Neuman J. New method for terminating cardiac arrhythmias: use of synchronized capacitor discharge. JAMA // 1962; 182: 548-555.
4. Paul M.H., Miller R.A. External electrical termination of supraventricular arrhythmias in congenital heart disease // Circulation. 1962; 25: 604-609.
5. Jensen J.B., Humphries J.O., Kouwenhoven W.B., Jude J.R. Electroshock for atrial flutter and atrial fibrillation: follow-up studies on 50 patients // JAMA. 1965; 194: 1181-1184.
6. Lown B., Perlroth M.G., Kaidbey S. et al. «Cardioversion» of atrial fibrillation: a report on the treatment of 65 episodes in 50 patients // N Engl J Med. 1963; 269: 325-331
7. Resnekov L., McDonald L. Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion // Br Heart J. 1967; 29: 926-936
8. Rokseth R. Clinical considerations in quinidine therapy of chronic auricular fibrillation. A study of 200 unselected patients with follow-up // Acta Med Scand. 1963; 174: 171-178.
9. Morris, J.J. Jr., Kong, Y., North, W.C. et al. Experience with «Cardioversion» of atrial fibrillation and flutter // Am J Cardiol. 1964; 14: 94-100.
10. Weinberg D.M., Mancini J. Anticoagulation for cardioversion of atrial fibrillation // Am J Cardiol. 1989; 63: 745-746.
11. Arnold A.Z., Mick M.J., Mazurek R.P. et al. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter // J Am Coll Cardiol. 1992; 19: 851-855.
12. Steering and Publications committees of the ACUTE Study. Design of a clinical trial for the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE multicenter study) // Am J Cardiol. 1998; 81: 877-883.
13. Bjerkelund C.J., Orning O.M. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation // Am J Cardiol. 1969; 23: 208-216.
14. Roy D., Marchand E., Gagné P. et al. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation // Am Heart J. 1986; 112: 1039-1043.
15. Klein A.L., Grimm R.A., Murray R.D. et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation // N Engl J Med. 2001; 344: 1411-1420.
16. Moreyra E., Finkelhor R.S., Cebul R.D. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials // Am Heart J. 1995; 129: 71-75.
17. De Caterina R., Husted S., Wallentin L. et al. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost. 2013; 110: 1087-1107.
18. Wilshire J., Smith A., Bohm A. et al. Routine unselected access to day case electrical cardioversion of persistent atrial fibrillation: anticoagulant preparation is the key factor // Scott Med J. 2004; 49: 26-29.
19. Weinberg D.M., Mancini J. Anticoagulation for cardioversion of atrial fibrillation // Am J Cardiol. 1989; 63: 745746.
20. Ruff C.T., Giugliano R.P., Braunwald E. et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a metaanalysis of randomised trials //Lancet. 2014; 383: 955-962.
21. January C.T, Wann S.L., Alpert J.S et al. 2014 AHA/ ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society // Circulation. 2014; 130: e199-e267.
22. Camm A.J., Lip G.Y.H., De Caterina R. et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association // Eur Heart J, 2012; 33: 2719-2747.
23. Nagaracanti R., Ezekowitz M.D., Oldgren J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. An analysis of Patients Undergoing Cardiversion // Circulation 2011; 123: 131-136.
24. Flaker G., Lopes R.D., Al-Khatib S.M. et al. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) // J Am Coll Cardiol. 2014; 63: 1082-1087.
25. Piccini J.P., Stevens S.R., Lokhnygina Y., et al. Outcomes following cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial // J Am Coll Cardiol. 2013; 61: 19982006.
26. Cappato R., Ezekowitz M.D., Klein A.L. et al. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation // Eur Heart J. 2014; 35: 3346-3355.
27. Heidbuchel H., Verhamme P., Alings А. et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation // Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology 2015, 17 (10): 1467-507.
Рецензия
Для цитирования:
Аверков О.В. ВЫБОР АНТИКОАГУЛЯНТА У БОЛЬНЫХ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ, ПОДВЕРГАЕМЫХ КАРДИОВЕРСИИ. Вестник аритмологии. 2015;(82):27-31.
For citation:
Averkov O.A. SELECTION OF ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING CARDIOVERSION. Journal of Arrhythmology. 2015;(82):27-31. (In Russ.)
Просмотров:
128
Послать статью по эл. почте 